4//SEC Filing
Vizirgianakis Stavros G. 4
Accession 0000899243-22-015851
CIK 0001665988other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 4:24 PM ET
Size
5.3 KB
Accession
0000899243-22-015851
Insider Transaction Report
Form 4
Vizirgianakis Stavros G.
Director
Transactions
- Award
Class A Common Stock
2021-10-29+2,780,923→ 2,780,923 total
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 29, 2021 (the "Merger Agreement"), each share of Misonix Inc. ("Misonix") common stock (a "Misonix Option") that was outstanding immediately prior to the effective time of the transactions contemplated by the Merger Agreement (the "Effective Time"), was converted into the right to receive a per share amount (the "Merger Consideration") equal to either an amount in cash equal to $28.00 or 1.6839 validly issued, fully paid and non-assessable shares of the Company's Class A Common Stock, $0.001 par value per share ("Bioventus Shares"). The transaction was exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3 promulgated thereunder.
Documents
Issuer
Bioventus Inc.
CIK 0001665988
Entity typeother
Related Parties
1- filerCIK 0001559834
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 4:24 PM ET
- Size
- 5.3 KB